• Skip to main content

DistilINFO LifeSciences

Weekly round up from Life Sciences Industry.

  • Publications
    • Home
    • DistilINFO HealthPlan
    • DistilINFO HospitalIT
    • DistilINFO IT
    • DistilINFO Retail
    • DistilINFO POPHealth
    • DistilINFO Ageing
    • DistilINFO Life Sciences
    • DistilINFO GovHealth
    • DistilINFO EHS
    • DistilINFO HealthIndia
    • Subscribe
    • Submit Article
    • Advertise
    • Newsletters

Bellingham Urology Group Acquires First ExactVu™ Micro-Ultrasound System in Washington State for Real-Time Targeted Prostate Biopsies

Share:

June 10, 2019

Exact Imaging, the world’s leader in high resolution micro-ultrasound systems enabling real-time imaging and biopsy guidance for the prostate, announced that Bellingham Urology Group has acquired the ExactVu™ micro-ultrasound system for real-time targeted prostate biopsies. This is the first of its kind in Washington, Oregon, and Idaho.

“At Bellingham Urology Group, we are dedicated to providing the highest level of patient care, and investments in the newest imaging technologies to allow our physicians to achieve these outcomes is essential”, says Dr. Vernon Orton, one of Washington’s most experienced urologic robotic surgeons. “Our acquisition of this ExactVu high resolution micro-ultrasound system will allow our urologists to actually visualize suspicious regions with 300% the image resolution of conventional ultrasound systems, and then target their prostate biopsies in real-time. Bellingham Urology Group patients will benefit from this excellent new platform that will allow us to ultimately improve our biopsies with the end goal of allowing our physicians to more accurately diagnose significant prostate cancer.” Dr. Orton adds “The ExactVu micro-ultrasound system is a paradigm shift in real-time imaging striving to get even more accurate biopsies using the highest resolution modalities to enable the fastest, most detailed imaging of the prostate. With the system’s FusionVu™ feature, we can also align the patient’s prostate MRI with the live micro-ultrasound image to either perform Cognitive Assist™ or micro-ultrasound/MRI fusion-guided biopsies, all with the benefit of the 70-micron resolution of micro-ultrasound. This allows us to see lesions that were unseen with our older technologies.”

“We are thrilled to have Bellingham Urology Group as the first practice in Washington, Oregon, and Idaho to adopt our ExactVu micro-ultrasound platform,” says Randy AuCoin, Exact Imaging’s President and CEO. “The ExactVu micro-ultrasound system provides the highest real-time resolution for targeted prostate biopsies and through this progressive urology practice, patients in the Northwestern U.S. can now have access to micro-ultrasound for their prostate biopsies”.

The ExactVu customer base is growing globally as the urological community is recognizing the power of micro-ultrasound for providing excellent resolution for visualizing the prostate and providing real-time targeted guidance of prostate biopsies in a manner that is fast, cost-effective, and convenient for the patient.

Want to publish your own articles on DistilINFO Publications?

Send us an email, we will get in touch with you.

Date: June 10, 2019

Source: Yahoo Finance

Coffee with DistilINFO's Morning Updates...

Sign up for DistilINFO e-Newsletters.

Just a little bit more about you...
PROCEED
Choose Lists
BACK

Related Stories

  • Accumen Acquires Medical Imaging Post-Processing Company 3DR LaboratoriesAccumen Acquires Medical Imaging Post-Processing Company 3DR Laboratories
  • Artificial Intelligence – Leading The Silent Revolution in HealthCareArtificial Intelligence – Leading The Silent Revolution in HealthCare
  • California Physician Practices to Use Apple Watches to Advance Physician-Patient CommunicationCalifornia Physician Practices to Use Apple Watches to Advance Physician-Patient Communication
  • Sciex Acquires Intabio, a Developer of Precision Solutions for Biotherapeutic Analysis Through Imaged Cief-msSciex Acquires Intabio, a Developer of Precision Solutions for Biotherapeutic Analysis Through Imaged Cief-ms
  • Arcturus Therapeutics Acquires Exclusive License to mRNA Manufacturing Technology from Alexion PharmaceuticalsArcturus Therapeutics Acquires Exclusive License to mRNA Manufacturing Technology from Alexion Pharmaceuticals
  • Strong action is needed to preserve the competitiveness of America’s life-science industriesStrong action is needed to preserve the competitiveness of America’s life-science industries
  • Making the Most of the Rising Biopharma M&AsMaking the Most of the Rising Biopharma M&As
  • Toby Cosgrove: Why We Need Artificial Intelligence in Health CareToby Cosgrove: Why We Need Artificial Intelligence in Health Care

Trending This Week

Sorry. No data so far.

About Us

DistilINFO is media company that publishes Industry news, views and Interviews. We distil the information for you – saving time and keeping you up to date on your interest areas.

More About Us

Follow Us


Useful Links

  • Subscribe
  • Contact
  • Advertise
  • Privacy Policy
  • Terms of Service
  • Feedback

All Publications

  • DistilINFO HealthPlan Advisory
  • DistilINFO HospitalIT Advisory
  • DistilINFO IT Advisory
  • DistilINFO Retail Advisory
  • DistilINFO POPHealth Advisory
  • DistilINFO Ageing Advisory
  • DistilINFO Life Sciences Advisory
  • DistilINFO GovHealth Advisory
  • DistilINFO EHS Advisory
  • DistilINFO HealthIndia Advisory

© DistilINFO Publications